ARTICLE | Financial News

Cold Genesys raises $10M in series B

August 7, 2015 2:03 AM UTC

Cold Genesys Inc. (Santa Ana, Calif.) raised $10 million in a series B round co-led by existing investor Ally Bridge Group and new investor WI Harper Group. New investors Whitesun Healthcare Ventures and Song Hong Fang also participated.

Cold Genesys COO Arthur Kuan told BioCentury the company expects to complete a pivotal Phase II trial in late 2018 of lead candidate CG0070 to treat bladder cancer. The company also plans to conduct Phase I/II studies of the modified adenovirus expressing GM-CSF in combination with immune checkpoint modulators. ...